MedinCell S.A. (EPA:MEDCL)
23.58
-0.62 (-2.56%)
Apr 24, 2026, 3:22 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €868.88 million as of April 24, 2026. Its market cap has increased by 104.63% in one year.
Market Cap
868.88M
Enterprise Value
888.97M
Revenue
32.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€23.58
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 868.88M, an increase of 494.69%. That is a compound annual growth rate of 26.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 868.88M | 4.16% |
| Dec 31, 2025 | 834.19M | 71.72% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.28B |
| DBV Technologies | 1.02B |
| Inventiva | 991.80M |
| Genfit | 454.13M |
| Valneva SE | 450.54M |
| Cellectis | 254.21M |
| Transgene | 208.15M |
| Sensorion | 194.82M |